MedTrace Logo

Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer

NCT07179809 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-09-18

No results posted yet for this study

Summary

The research study is to learn how the ACLP can best support patients with stable HR+/HER2- MBC.

Conditions

Interventions

OTHER

Demographics/Lifestyle Survey

Participants will complete all sessions and instruments

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Meroe Morse, MD · M.D. Anderson Cancer Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2027-10-01
Completion
2029-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07179809 on ClinicalTrials.gov